SynBioBeta Speaker
Jayme Feyhl-Buska
Homeworld Collective
Critical Minerals Lead
Jayme Feyhl-Buska is a geomicrobiologist focused on leveraging the natural interactions between biology and geology to develop technologies that address climate issues. She started her geomicrobiology studies researching extremophilic life in the hot springs of Yellowstone National Park during her bachelors studies at Montana State University. At the University of Southern California, she continued her research into astrobiology and the limits of life, working to clarify energy and nutrient usage in deep subsurface microbes inhabiting a volcanic subglacial lake and a former gold mine. Following her PhD, Jayme honed her skills in applied geomicrobiology as an industry scientist, first developing agricultural biotechnologies at Boost Biomes, then specializing in biomining copper from low-grade ores at Cemvita and later through its spinoff, Endolith. Today, as the Critical Minerals Program Lead at Homeworld Collective, she continues to focus on how to develop better biomining biotechnologies capable of leveraging biology for the benefit of humanity and the environment.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Jayme
This Year
•
-
Planetary Health
DNA Over Dynamite: How Biomining is Transforming Resource Recovery
Mining has long relied on brute force and chemistry, but biology is opening a new frontier. Biomining uses engineered microbes to extract metals and minerals with precision, efficiency, and far less environmental impact than traditional methods. From rare earth elements essential to clean energy to critical metals powering electronics, synthetic biology is reshaping how we source the building blocks of modern life. This session spotlights innovators designing bio-based recovery systems, scaling sustainable solutions, and reimagining resource extraction.
Purchase Pass
Featuring
Jayme Feyhl-Buska
Homeworld Collective
Critical Minerals Lead
Geomicrobiology builder turning microbes into cleaner mining tech
Nicole Richards
Allonnia
CEO
Chemical-to-cleanup veteran leading bioremediation’s next wave.
Eileen Spindler
Alta Resource Tech
VP of R&D
Mining rare earth elements with enzymes
Samuel Jayakanthan
Vandstrom
Research Director
Protein nanochannel engineer chasing cheaper desalination at scale.
Luis Valencia
AlkaLi Labs
Co-Founder & CEO
Collaborating with microbes to recycle waste
•
-
Planetary Health
DNA Over Dynamite: How Biomining is Transforming Resource Recovery
Mining has long relied on brute force and chemistry, but biology is opening a new frontier. Biomining uses engineered microbes to extract metals and minerals with precision, efficiency, and far less environmental impact than traditional methods. From rare earth elements essential to clean energy to critical metals powering electronics, synthetic biology is reshaping how we source the building blocks of modern life. This session spotlights innovators designing bio-based recovery systems, scaling sustainable solutions, and reimagining resource extraction.
Purchase Pass
Featuring
Jayme Feyhl-Buska
Homeworld Collective
Critical Minerals Lead
Geomicrobiology builder turning microbes into cleaner mining tech
Nicole Richards
Allonnia
CEO
Chemical-to-cleanup veteran leading bioremediation’s next wave.
Eileen Spindler
Alta Resource Tech
VP of R&D
Mining rare earth elements with enzymes
Samuel Jayakanthan
Vandstrom
Research Director
Protein nanochannel engineer chasing cheaper desalination at scale.
Luis Valencia
AlkaLi Labs
Co-Founder & CEO
Collaborating with microbes to recycle waste
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
